The report Regurgitation Global Clinical Trials Review, H1, 2018 gives an overview of the global clinical trials landscape and
top-level data related to clinical trials by Regio, Country (G7 and E7), Trial
Status, trial Phase, Sponsor type and End point status. The report reviews top
companies involved and enlists all trials (Trial title, Phase, and Status)
pertaining to the company and all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for their non-accomplishments. It provides
enrolment trends for the past five years and the latest news relating to these
trials for the past three months. The companies involved in the clinical trials
of Regurgitation are AstraZeneca Plc, Novartis AG,
Healthypharm BV, SOFAR SpA, Pierre Fabre Foundation, Pacira Pharmaceuticals
Inc, Johnson & Johnson, GlaxoSmithKline Plc, C. H. Boehringer Sohn AG &
Co KG and BioGaia AB. The report will
enhance the decision- making capabilities and helps to create an effective
counter strategy to gain competitive advantage.
Regurgitation
is a disorder where food or liquid moves back up from the stomach and exits
through the mouth. It requires very minimal effort andnausea. The real cause of
regurgitation is unknown but frequent regurgitation may lead to severe health
disorders. However, digestive issues, oesophageal sphincter, Parkinson’s
disease, sclerosis show the symptoms of regurgitation. The symptoms include
abdominal pain, effortless vomiting, bloating, constipation, dental erosion.
Regurgitation may lead to serious other problems if left unattended and can be
prevented with a few changes towards a healthier lifestyle.
Clinical
trials are conducted in medical research labs to find better ways to prevent
and treat diseases or diagnose them. They give solutions on the medical
approaches suitable for certain illness to a certain group of people
specifically. These trials help a great deal in making healthcare decisions.
Since they answer scientific questions, these trials are required to be carried
on under strict and scientific standards that protect the interests of the
patients. They are also the final and the most important stage of clinical
research and development. Clinical trials for drugs take place in four phases-
first, they test an experimental drug on a few people and study the effects;
second, they test the drug on more people than in Phase 1 which may extend up
to years; third, they include many other participants to test for safety and
efficacy and study the side effects deeper than in Phase 2; fourth, getting
approval of the usage of drug from the relevant authority.
To know more, click on the link below:-
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment